New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
10:01 EDTMTGE, VOD, VOXX, URBN, TOT, STO, SWN, O, PHMD, LFL, ITC, HII, CXP, BMY, BEAV, AAUKY, WACOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Capital Mortgage (MTGE) downgraded to Market Perform at JMP Securities... Anglo American (AAUKY) downgraded to Neutral from Outperform at Credit Suisse... BE Aerospace (BEAV) downgraded to Neutral from Buy at UBS... Bristol-Myers (BMY) downgraded at BMO Capital... Columbia Property Trust (CXP) downgraded to Equal Weight from Overweight at Morgan Stanley... Huntington Ingalls (HII) downgraded at BofA/Merrill... ITC Holdings (ITC) downgraded to Neutral from Overweight at JPMorgan... LATAM Airlines (LFL) downgraded to Market Perform from Outperform at Raymond James... PhotoMedex (PHMD) downgraded to Hold from Buy at Ascendiant... Realty Income (O) downgraded to Neutral from Buy at Ladenburg... Southwestern Energy (SWN) downgraded to Neutral from Conviction Buy at Goldman... Statoil (STO) downgraded to Sector Perform from Top Pick at RBC Capital... Total (TOT) downgraded to Sector Perform from Outperform at RBC Capital... Urban Outfitters (URBN) downgraded to Market Perform from Outperform at FBR Capital... VOXX International (VOXX) downgraded to Neutral from Buy at B. Riley... Vodafone (VOD) downgraded to Neutral from Buy at Goldman... Walter Investment (WAC) downgraded to Sell from Neutral at Compass Point.
News For MTGE;AAUKY;BEAV;BMY;CXP;HII;ITC;LFL;PHMD;O;SWN;STO;TOT;URBN;VOXX;VOD;WAC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
October 13, 2014
06:36 EDTTOTSaudi Arabia content to let oil prices stay low, Reuters reports
Subscribe for More Information
05:24 EDTAAUKYAnglo American upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
05:18 EDTSTOStatoil sells 15.5% share in Shah Deniz to PETRONAS for $2.2B
Statoil has sold its 15.5% participating interest in the Shah Deniz production sharing agreement, 15.5% share in the South Caucasus Pipeline Company, or SCPC, 15.5% share in the SCPC holding company, and 12.4% share in the Azerbaijan Gas Supply Company, or AGSC, to the Malaysian oil and gas company PETRONAS. The transaction value is $2.25B. Statoil's Q2 production from the Shah Deniz field was 38,000 barrels of oil equivalent per day. The effective date is January 1. The transaction is expected to be closed early 2015, subject to approval from the relevant authorities.
05:16 EDTSTOStatoil sells 15.5% share in Shah Deniz to PETRONAS for $2.2B
Subscribe for More Information
October 12, 2014
13:53 EDTTOTKuwaiti Minister says OPEC unlikely to cut production, WSJ says
Subscribe for More Information
13:45 EDTTOTSaudis take aggressive oil measures in Europe, WSJ says
Subscribe for More Information
October 10, 2014
16:20 EDTWACBaker Street Capital reports 11.3% passive stake in Walter Investment
Subscribe for More Information
10:03 EDTBMYBristol-Myers receives orphan status for melanoma treatment
Subscribe for More Information
08:19 EDTBMYMedivir announces Janssen initiates enrolment in phase II IMPACT study
Subscribe for More Information
October 9, 2014
18:47 EDTVOXXOn The Fly: After Hours Movers
UP AFTER EARNINGS: Helen of Troy (HELE), up 3%... Barracuda Networks (CUDA), up marginally after reporting second quarter results. ALSO HIGHER: Sucampo Pharmaceuticals (SCMP), up 19.2% after announcing settlement agreement resolving patent litigation on AMITIZA... Civeo (CVEO), up 15% after Greenlight Capital reported a 9.99% stake in the company... EXCO Resources (XCO), up 10.6% after T. Boone Pickens says that company approached by buyers, reported by Bloomberg... EXACT Sciences (EXAS), up 3.7% after announcing final national coverage determination for Cologuard... US Ecology (ECOL), up 2.5% following announcement that it will replace Measurement Specialties (MEAS) in S&P 600. DOWN AFTER EARNINGS: Procera Networks (PKT), down 19.3%... Sizmek (SZMK), down 13.9% following third quarter revenue guidance... VOXX International (VOXX), down 12.5%... Knowles (KN), down 8.1% after lowering third quarter guidance... Microchip (MCHP), down 8.2% after lowering second quarter guidance... Juniper Networks (JNPR), down 3.6% after lowering third quarter outlook. ALSO LOWER: GT Advanced Technologies (GTAT), down 23.3% following a Bloomberg report that it will as to wind down sapphire operations.
17:32 EDTVOXXVOXX International down 16% following Q2 results
Subscribe for More Information
17:07 EDTVOXXVOXX International reports Q2 EPS (11c), may not compare to consensus 6c
Subscribe for More Information
15:24 EDTVOXXNotable companies reporting after market close
Subscribe for More Information
10:50 EDTURBNGap falls after announcing CEO Murphy will step down, weak September sales
Subscribe for More Information
10:00 EDTVODOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:27 EDTVODVodafone downgraded to Reduce from Neutral at Nomura
Subscribe for More Information
October 8, 2014
10:38 EDTBEAVHigh option volume stocks
High option volume stocks: FRAN RMTI ACM CY CLNY SMH BEAV SIG CTB DUG SHLD
08:03 EDTBMYBristol-Myers resolves outstanding U.S. litigation on efavirenz
Bristol-Myers Squibb Company says it has "successfully resolved all outstanding U.S. patent litigation relating to efavirenz, an active ingredient contained in our Sustiva -- efavirenz -- and Atripla products. Accordingly, we believe that loss of exclusivity in the U.S. for efavirenz should not occur until December 2017. Bristol-Myers Squibb remains committed to delivering our medicines and to developing new and innovative treatments to help patients prevail over serious disease. Atripla is currently the #1 prescribed U.S. regimen in its category, with over 8 million prescriptions written since its launch in 2006. Earlier this year the company submitted a new drug application to the U.S. Food and Drug Administration for a fixed-dose combination of atazanavir sulfate and cobicistat, an investigational pharmacokinetic enhancer. In addition, studies are ongoing for new treatments including an HIV-1 attachment inhibitor, an HIV-1 maturation inhibitor and an anti-PD-L1. The establishment of intellectual property rights allows Bristol-Myers Squibb to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We will continue to defend our intellectual property rights against infringement as we remain focused on providing a deep and broad portfolio of innovative medicines to patients around the world."
07:18 EDTBMYInfectious Diseases Society of America to hold a conference
ID Week 2014 is being held in Philadelphia on October 8-12.
06:48 EDTVODSwisscom mulls $6.3B Fastweb deal as Vodafone waits, Reuters says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use